Johnson & Johnson JNJ

$278.70 -3.85 (-1.36%)

Valuation

Market cap
687,888,896,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
26.62
P/E (forward)
25.50
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
8,051,418
Avg volume
7,314,380
Day's range
$277.56 – $281.72
Shares out
2,407,310,000
Stochastic %K
69%
Beta
0.22
Analysts
Moderate Buy
Price target
$281.64

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

SellasgpsCurativeBAT11 Nov 17, 8:26 PM
$INO $SLS $MRK $JNJ $BMY Deal coming up Next. ✌️🙏❤️‍🩹
0 replies
BarkingPuppy Nov 17, 7:58 PM
$ELTP $PFE $JNJ $MRNA Here We Go Elite Pharmaceuticals !!!!
0 replies
DollarFlipper Nov 17, 7:42 PM
$SPY $QQQ bullish for now $BSX $JNJ
1 replies
Half_Trader_Reloaded Nov 17, 6:47 PM 1 replies
ZSchafes Nov 17, 6:00 PM
$SLS open up that checkbook $JNJ
1 replies
CasperPuff Nov 17, 5:49 PM 0 replies
zioni007 Nov 17, 5:05 PM
$SLS Hmmmm $JNJ BO
0 replies
PB09 Nov 17, 4:48 PM
I call $JNJ to take out $SLS for $8B+ by end of January.
2 replies